DrugPatentWatch Database Preview
ZOHYDRO ER Drug Profile
Which patents cover Zohydro Er, and when can generic versions of Zohydro Er launch?
Zohydro Er is a drug marketed by Persion and is included in one NDA. There are sixteen patents protecting this drug and one Paragraph IV challenge.
This drug has one hundred and sixty patent family members in thirty-four countries.
The generic ingredient in ZOHYDRO ER is hydrocodone bitartrate. There are twenty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydrocodone bitartrate profile page.
Summary for ZOHYDRO ER
| International Patents: | 160 |
| US Patents: | 16 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 10 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ZOHYDRO ER |
| Drug Sales Revenues: | Drug sales revenues for ZOHYDRO ER |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ZOHYDRO ER |
| DailyMed Link: | ZOHYDRO ER at DailyMed |
See drug prices for ZOHYDRO ER
Recent Litigation for ZOHYDRO ER
Identify potential future generic entrants
District Court Litigation
| Case Name | Date |
|---|---|
| Recro Gainesville LLC v. Actavis Laboratories FL, Inc. | 2017-10-30 |
| Pernix Ireland Pain Ltd. v. Actavis Laboratories FL, Inc. | 2016-03-04 |
| Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. | 2015-09-15 |
Pharmacology for ZOHYDRO ER
| Drug Class | Opioid Agonist |
| Mechanism of Action | Opioid Agonists |
US Patents and Regulatory Information for ZOHYDRO ER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Persion | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-005 | Oct 25, 2013 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Persion | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-003 | Oct 25, 2013 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Persion | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-002 | Oct 25, 2013 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Persion | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-006 | Oct 25, 2013 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Persion | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-004 | Oct 25, 2013 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZOHYDRO ER
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Capsules | 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, and 50 mg | ➤ Subscribe | Start Trial |
International Patents for ZOHYDRO ER
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20090023729 | Start Trial |
| Australia | 2005247019 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2016038584 | Start Trial |
| Japan | 2008545808 | Start Trial |
| Norway | 20090158 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
